SCHEMBL14909796

SCHEMBL14909796

Cc1cccc(Nc2nc(NC3CCCCC3N)c(F)cc2C(N)=O)c1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FER P16591 10/20 0.79
▸ SYK P43405 10/20 0.73
▸ MAPK1 P28482 3/20 0.70
▸ MAPK3 P27361 2/20 0.70
▸ KCNH2 Q12809 2/20 0.70
▸ AURKB Q96GD4 2/20 0.70
▸ GP6 Q9HCN6 1/20 0.70
▸ CDC7 O00311 1/20 0.62
▸ PLK4 O00444 1/20 0.62
▸ CHEK1 O14757 1/20 0.62
▸ PDPK1 O15530 1/20 0.62
▸ DAPK3 O43293 1/20 0.62
▸ DYRK3 O43781 1/20 0.62
▸ JAK2 O60674 1/20 0.62
▸ ROCK2 O75116 1/20 0.62
▸ RPS6KA5 O75582 1/20 0.62
▸ PRKD3 O94806 1/20 0.62
▸ MAP4K4 O95819 1/20 0.62
▸ PAK4 O96013 1/20 0.62
▸ CHEK2 O96017 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9106025 1.00 FER (0.79) FERSYKMAPK1MAPK3KCNH2
SCHEMBL14928519 1.00 FER (0.79) FERSYKMAPK1MAPK3KCNH2
SCHEMBL14929115 0.91 FER (0.65) FERSYKMAPK1MAPK3KCNH2
SCHEMBL14909740 0.91 FER (0.65) FERSYKMAPK1MAPK3KCNH2
SCHEMBL9109203 0.91 FER (0.65) FERSYKMAPK1MAPK3KCNH2
SCHEMBL16164019 0.90 FER (0.66) FERSYKMAPK1MAPK3KCNH2
SCHEMBL5027524 0.90 SYK (0.66) FERSYKMAPK1MAPK3KCNH2
SCHEMBL5028172 0.89 SYK (0.67) FERSYKMAPK1MAPK3KCNH2
SCHEMBL20750828 0.89 SYK (0.67) FERSYKMAPK1MAPK3KCNH2
SCHEMBL20750794 0.89 FER (0.65) FERSYKMAPK1MAPK3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2589592-B1 NOVEL NICOTINAMIDE DERIVATIVES OR SALTS THEREOF FUJIFILM CORP (JP) 2018-08-22 — — EP claimed
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 — — US claimed
US-8809371-B2 — — 2014-08-19 — — US claimed
US-8772320-B2 — — 2014-07-08 — — US claimed
EP-3176154-B1 BENZAMIDES AND NICOTINAMIDES AS SYK MODULATORS PORTOLA PHARM INC (US) 2019-02-20 — — EP disclosed
EP-2589592-B1 NOVEL NICOTINAMIDE DERIVATIVES OR SALTS THEREOF FUJIFILM CORP (JP) 2018-08-22 — — EP disclosed
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 — — US disclosed
US-8809371-B2 — — 2014-08-19 — — US disclosed
US-8772320-B2 — — 2014-07-08 — — US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 — — US disclosed
EP-2589592-A1 NOVEL NICOTINAMIDE DERIVATIVES OR SALTS THEREOF FUJIFILM Corporation (JP) 2013-05-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, CD38, BTK FER 919/4885SYK 1/4885MAPK1 334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback